scispace - formally typeset
A

Angel L. Armesilla

Researcher at University of Wolverhampton

Publications -  54
Citations -  3321

Angel L. Armesilla is an academic researcher from University of Wolverhampton. The author has contributed to research in topics: Plasma membrane Ca2+ ATPase & Signal transduction. The author has an hindex of 30, co-authored 52 publications receiving 2944 citations. Previous affiliations of Angel L. Armesilla include Autonomous University of Madrid & Spanish National Research Council.

Papers
More filters
Journal ArticleDOI

Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties.

TL;DR: Disulfiram/copper inhibited BCSCs and enhanced cytotoxicity of PAC in BC cell lines and may be caused by simultaneous induction of ROS and inhibition of NFκB.
Journal ArticleDOI

Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells.

TL;DR: The findings indicate that the cytotoxicity of DS/Cu and the enhancing effect ofDS/Cu on the cytOToxicity of dFdC in GBM stem-like cells may be caused by induction of ROS and inhibition of both ALDH and the NFkB pathway.
Journal ArticleDOI

Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility.

TL;DR: It is shown that homozygous male mice with a targeted gene deletion of isoform 4 of the plasma membrane calcium/calmodulin-dependent calcium ATPase (PMCA), which is highly enriched in the sperm tail, are infertile due to severely impaired sperm motility, supporting the hypothesis of a pivotal role of the PMCA4 on the regulation of sperm function and intracellular Ca2+ levels.
Journal ArticleDOI

Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression.

TL;DR: NFAT was involved in the VEGF-mediated TF promoter activation as evidenced by cotransfection experiments with a dominant negative version of NFAT and site-directed mutagenesis of a newly identified NFAT site within the TF promoter that overlaps with a previously identified κB-like site.
Journal ArticleDOI

Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells

TL;DR: Disulfiram abolished CSC characters and completely reversed PAC and CDDP resistance in MDA-MB-231PAC10 cells, suggesting cancer stem cells may be responsible for acquired pan-chemoresistance.